Aytu Biopharma, Inc. (AYTU) CEO Josh Disbrow on Q1 2022 Results – Earnings Call Transcript
Aytu Biopharma, Inc. (NASDAQ:AYTU) Q1 2022 Earnings Conference Call November 16, 2021 4:30 PM ET
Company Participants
Josh Disbrow – Chairman and Chief Executive Officer
Richard Eisenstadt – Chief Financial Officer
Conference Call Participants
Jennifer…
